Filing metadata

Accession number
0001209191-21-002477
Form type
Form 4
Filer
Damora Therapeutics, Inc.
CIK
CIK 1800315
Filed
Jan 07, 2021
Reporting period
Jan 05, 2021
Description
Insider transaction

Explore SEC Filings Hub